Principal Biologist

Principal Biology role

Join Aqemia in a role where you will help shape our rapidly expanding portfolio of small molecule programs across diverse therapeutic areas, beginning with oncology and immuno‑oncology. This is a unique chance to build a pipeline working closely with the VP of biology, and multidisciplinary teams to accelerate the discovery of clinical candidates.

You’ll become part of a dedicated team focusing on providing biological support across the Aqemia portfolio.

We provide an inspiring and ambitious work environment, where we are changing the way drug discovery is performed.

Reporting to the VP of biology, you have a rare opportunity to impact our portfolio progression. We do not have an internal wetlab to keep agility, thus we work with leading Contract Research Organizations (CROs) for synthesis, in vitro assays, and in vivo assays.

Your responsibilities

• Driving and facilitating new drug discovery project ideas providing biological support in identifying, validating and selecting targets with clear unmet needs in disease.
• Supporting early internal innovation activities with strong molecular understanding, biological insights, and a value chain overview. Integrating successful projects into the Aqemia pipeline research pipeline, guiding them towards proof of concept.
• Supporting project teams with screening cascade design and maintenance.
• Interacting with external contract research organisations to identify appropriate models to deliver high quality datasets supporting project progression.

What makes you a perfect fit

• We are looking for an objective‑driven biologist who:
• Challenges themselves and others while integrating expertise from internal teams.
• Has a passion for bringing new drugs to market with a proactive and can‑do attitude.
• Utilizes a data‑driven and rigorous approach.
• Values team success over individual achievements and excels in concise, efficient communication.

Your qualifications & skills

• Education: A Ph.D. in biological sciences (such as pharmacology, chemical biology, biochemistry, molecular biology), or alternatively, a master’s degree with significant relevant industrial research experience.
• Experience: Strong background in drug discovery, with experience in transitioning projects from hit identification to candidate nomination.
• Preferably, 8+ years of relevant industrial experience within early drug discovery and ideation.
• Hands‑on skills: Wet lab experience to effectively challenge and collaborate with CROs.
• Specialization: Experience in oncology and/or immuno‑oncology is mandatory. A talent for driving and fostering innovation closely aligned with business strategies.
• Soft skills:
• The ability to thrive in a fast‑paced and dynamic environment, with resilience in the face of challenges, setbacks, and ambiguity.
• Experience in supporting project teams in identifying risks within their projects.
• Experience in research project management in multidisciplinary teams in a complex stakeholder environment is an advantage.

Why Join Us ?

At AQEMIA, we work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast‑growing company and team.

Expanding Drug Discovery Pipeline : Focused on critical therapeutic areas like Oncology, CNS, Immuno‑inflammation with in vivo proof of concept/patent stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.

World‑Class Interdisciplinary Team : work alongside exceptional talent at the intersection of technology and life sciences. Our teams combine deep expertise in AI, physics‑based modeling, biology, and medicinal chemistry to push the boundaries of innovation.

DeepTech Recognition : AQEMIA is proud to be part of the French Tech 120 and France 2030 , highlighting our role as a key player in Europe’s DeepTech ecosystem.

Prime Location with Flexibility : Our offices are located in the heart of Paris and London (King’s Cross) , with flexible work arrangements including up to two remote days per week.

Strong Financial Backing : $100M raised from leading European and International investors